Viewing nowDarim Esomeprazole Tablets 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

MFDS item code 201906201 · Approved 2019.08.30 · Insurance code 664602340
Treatment of acid-related disorders (including reflux and ulcers), NSAID-related gastrointestinal disorders, and Helicobacter pylori eradication
This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive reflux esophagitis, and for long-term maintenance therapy to prevent recurrence of esophagitis. It is also effective in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used to treat and prevent recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection and helps treat and prevent upper gastrointestinal symptoms and gastric ulcers related to non-steroidal anti-inflammatory drugs. It can also be used in the treatment of Zollinger-Ellison syndrome and is effective in preventing rebleeding of gastric or duodenal ulcers after intravenous administration. It is used to improve various gastrointestinal disorders and associated symptoms and lesions.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed dosing is not recommended to control recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. No clinical studies exceeding 4 weeks have been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into two doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this medicine. 6. Older adults: No dose adjustment is necessary.
Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. Children under 12 years of age: There is no experience with administering this medicine to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients who are allergic to this medication or have experienced hypersensitivity reactions should not take it. Caution is also required for patients taking certain antibiotics or other medications, as there may be risks of side effects or interactions. In particular, women who are breastfeeding and patients with a history of myocardial infarction should not take this medication. When taking this medication, various adverse reactions may occur. Symptoms such as headache, abdominal pain, diarrhea, nausea, and vomiting are commonly reported, and rarer serious side effects such as blood abnormalities, hypersensitivity reactions, liver function abnormalities, and skin rashes have also been reported. If any of these adverse reactions occur, consult healthcare professionals immediately. Regular check-ups are necessary for long-term use of this medication. Especially for those taking it for more than a year, periodic blood tests or checks of overall health are important. It is also crucial to consult a doctor for any changes in symptoms to receive appropriate action. This medication can interact with other drugs, so if you are taking other medications, you must inform your healthcare providers. In particular, when taken with antibiotics, antivirals, anticoagulants, anticonvulsants, etc., there may be changes in drug concentrations, requiring caution. The safety of this medication during pregnancy has not been fully established, so caution should be exercised when administered to pregnant women. For those who are breastfeeding, it is recommended to avoid this medication as it is unknown if it can be transmitted through breast milk. In cases of overdose, there is no specific antidote; therefore, appropriate treatment and monitoring are necessary based on symptoms. This medication binds well within the body and is not removed by dialysis. Finally, this medication should be kept out of the reach of children, and care should be taken not to transfer it to other containers as it may compromise quality and safety.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, altered perception, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia, and systemic drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, sub-sternal chest pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, otitis, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory reduction, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disturbances, tremors, visual field defect, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered smell, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, urinary difficulty, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This ensures that the medication's efficacy is preserved for a longer time and can be used safely.
Pink round film-coated tablet
Box - 28 tablets/bottle [14 tablets/PTP × 2], bottle - 30 tablets/bottle, bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.